Tiagabine Hydrochloride (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Tiagabine Hydrochloride drug offered from Avera McKennan Hospital. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | Tiagabine Hydrochloride |
SUBSTANCE NAME: | TIAGABINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2015-03-10 |
END MARKETING DATE: | 0000-00-00 |
Tiagabine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Tiagabine Hydrochloride from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(mg/1) |
START MARKETING DATE: | 2015-03-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0602_6b62b6bd-cbd2-41be-9f7c-434abae09762 |
PRODUCT NDC: | 69189-0602 |
APPLICATION NUMBER: | NDA020646 |
Other TIAGABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: